Inventor · disambiguated record
Klaus-Peter Hirth
Also filed as: HIRTH KLAUS P · HIRTH KLAUS-PETER
33 granted patents·12 pending applications·2,265 citations·filing 1991–2017
98Inventor score
Top patents by PatentIndex Score
45 records- 0198US8470818B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2010·Granted Jun 25, 2013·94 cites·56 claims
- 0298US8415469B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2009·Granted Apr 9, 2013·84 cites·18 claims
- 0398US8143271B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2011·Granted Mar 27, 2012·124 cites·8 claims
- 0498US7863288B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2006·Granted Jan 4, 2011·187 cites·54 claims
- 0598US5789427AMethods and compositions for inhibiting cell proliferative disordersSUGEN INC·Filed 1995·Granted Aug 4, 1998·264 cites·16 claims
- 0698US5773476AMethods and compositions for inhibiting cell proliferative disordersSUGEN INC·Filed 1995·Granted Jun 30, 1998·153 cites·17 claims
- 0797US9730918B2Kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Aug 15, 2017·25 cites·3 claims
- 0897US9358235B2Kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Jun 7, 2016·41 cites·3 claims
- 0996US7872018B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2007·Granted Jan 18, 2011·48 cites·12 claims
- 1095US5990141ATreatment of platelet derived growth factor related disorders such as cancersSUGEN INC·Filed 1995·Granted Nov 23, 1999·189 cites·20 claims
- 1195US5763198AScreening assays for compoundsSUGEN INC·Filed 1994·Granted Jun 9, 1998·155 cites·22 claims
- 1294US6610688B24-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitorsSUGEN INC·Filed 2000·Granted Aug 26, 2003·74 cites·22 claims
- 1394US5700823ATreatment of platelet derived growth factor related disorders such as cancersSUGEN INC·Filed 1994·Granted Dec 23, 1997·122 cites·23 claims
- 1492US10123998B2Kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Nov 13, 2018·9 cites·13 claims
- 1592US9873700B2Compounds for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Jan 23, 2018·20 cites·8 claims
- 1691US6331555B1Treatment of platelet derived growth factor related disorders such as cancersUNIV CALIFORNIA·Filed 1999·Granted Dec 18, 2001·152 cites·15 claims
- 1790US6696448B23-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitorsSUGEN INC·Filed 2002·Granted Feb 24, 2004·65 cites·4 claims
- 1890US6596878B2Methods and compositions for inhibiting cell proliferative disordersYISSUM RES & DEV COMPANY OF TH·Filed 2001·Granted Jul 22, 2003·26 cites·11 claims
- 1990US5942385AMethod for molecular diagnosis of tumor angiogenesis and metastasisSUGEN INC·Filed 1996·Granted Aug 24, 1999·145 cites·19 claims
- 2089US6147106AIndolinone combinatorial libraries and related products and methods for the treatment of diseaseSUGEN INC·Filed 1997·Granted Nov 14, 2000·37 cites·15 claims
- 2188US10421761B2Compounds for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Sep 24, 2019·6 cites·11 claims
- 2288US5700822ATreatment of platelet derived growth factor related disorders such as cancersUNIV CALIFORNIA·Filed 1995·Granted Dec 23, 1997·67 cites·24 claims
- 2385US6004967APsoriasis treatment with quinazoline compoundsSUGEN INC·Filed 1997·Granted Dec 21, 1999·74 cites·8 claims
- 2479US6906093B2Indolinone combinatorial libraries and related products and methods for the treatment of diseaseSUGEN INC·Filed 2001·Granted Jun 14, 2005·9 cites·2 claims
- 2575US7202265B2Indolinone combinatorial libraries and related products and methods for the treatment of diseaseSUGEN INC·Filed 2004·Granted Apr 10, 2007·4 cites·6 claims
- 2674US6908930B24-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitorsSUGEN INC·Filed 2003·Granted Jun 21, 2005·6 cites·12 claims
- 2772US7217737B2Method and compositions for inhibiting cell proliferative disordersSUGEN INC·Filed 2003·Granted May 15, 2007·3 cites·15 claims
- 2871US5932602ATreatment of platelet derived growth factor related disorders such as cancersSUGEN INC·Filed 1995·Granted Aug 3, 1999·26 cites·25 claims
- 2969US6316479B1Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disordersSUGEN INC·Filed 1998·Granted Nov 13, 2001·10 cites·22 claims
- 3065US2018111929A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Application pending·0 cites
- 3165US2013261117A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Application pending·0 cites
- 3263US2013303534A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Application pending·0 cites
- 3361US6649635B2Heteroarylcarboxamide compounds active against protein tyrosine kinase related disordersSUGEN INC·Filed 2001·Granted Nov 18, 2003·1 cites·24 claims
- 3461US5958959ATreatment of platelet derived growth factor related disorders such as cancersSUGEN INC·Filed 1995·Granted Sep 28, 1999·15 cites·16 claims
- 3560US2016176865A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2015·Application pending·0 cites
- 3660US2012053177A1Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2011·Application pending·0 cites
- 3758US2015290205A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2015·Application pending·0 cites
- 3855US2001018186A1Method for molecular diagnosis of tumor angiogenesis and metastasisFiled 2001·Application pending·0 cites
- 3953US2004102489A1Heteroarylcarboxamide compounds active against protein tyrosine kinase related disordersSUGEN INC·Filed 2003·Application pending·0 cites
- 4052US6846839B1Methods for treating diseases and disorders related to unregulated angiogenesis and/or vasculogenesisSUGEN INC·Filed 1999·Granted Jan 25, 2005·29 cites·9 claims
- 4150US2003108946A1Indolinone combinatorial libraries and related products and methods for the treatment of diseaseSUGEN INC·Filed 2002·Application pending·0 cites
- 4248US2002022626A1Indolinone combinatorial libraries and related products and methods for the treatment of diseaseFiled 2000·Application pending·0 cites
- 4342US2004171062A1Methods for the design of molecular scaffolds and ligandsPLEXXIKON INC·Filed 2003·Application pending·0 cites
- 4427US6538110B1Monoclonal antibodies against the interleukin 2 receptorROCHE DIAGNOSTICS·Filed 1991·Granted Mar 25, 2003·1 cites·8 claims
- 4522US2003219380A1Method of determining an efficacious dose of a drugFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Klaus-Peter Hirth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →